Downingtown, PA, United States of America

Bradley McIntyre

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bradley McIntyre

Introduction

Bradley McIntyre is an accomplished inventor based in Downingtown, PA (US). He has made significant contributions to the field of cancer treatment through his innovative work. His expertise and dedication have led to the development of valuable patents that aim to improve patient outcomes.

Latest Patents

One of McIntyre's notable patents is focused on bendamustine derivatives and methods of using them. This invention is directed to bendamustine esters and bendamustine amides, which are utilized for the treatment of cancer. His work in this area has the potential to enhance therapeutic options for patients battling this disease. He holds 1 patent in total.

Career Highlights

Bradley McIntyre is currently associated with Ignyta, Inc., a company dedicated to advancing cancer therapies. His role at the company allows him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Roger P. Bakale and Peter D. Brown. Their collective efforts contribute to the innovative environment at Ignyta, Inc., fostering advancements in cancer treatment.

Conclusion

Bradley McIntyre's contributions to the field of cancer treatment through his patent on bendamustine derivatives exemplify his commitment to innovation. His work continues to inspire advancements in medical therapies that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…